Theophylline given for bronchial asthma acts by inhibiting phophodiesterose enzyme. It also acts by inhibiting:
## **Core Concept**
Theophylline is a methylxanthine drug used in therapy for respiratory diseases such as chronic obstructive pulmonary disease (COPD) and asthma. It belongs to a class of drugs known as phosphodiesterase inhibitors. The primary mechanism of action involves the inhibition of phosphodiesterase (PDE) enzymes, which leads to increased levels of cyclic AMP (cAMP) and cyclic GMP (cGMP) within cells. This results in smooth muscle relaxation, decreased inflammation, and increased contraction of the diaphragm.
## **Why the Correct Answer is Right**
The correct answer involves understanding the additional mechanisms through which theophylline exerts its effects. Besides inhibiting phosphodiesterase enzymes, theophylline also acts as an **adenosine receptor antagonist**. Adenosine typically promotes sleep, suppresses arousal, and has various other physiological effects. In the context of asthma and COPD, adenosine can cause bronchoconstriction. By blocking adenosine receptors, theophylline contributes to its therapeutic effects, including bronchodilation.
## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is blank and cannot be evaluated.
- **Option B:** This option is blank and cannot be evaluated.
- **Option C:** This option is blank and cannot be evaluated.
- **Option D:** This option is blank and cannot be evaluated.
## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that theophylline has a narrow therapeutic index, meaning the difference between an effective dose and a toxic dose is small. Monitoring of serum levels is often required to ensure efficacy while minimizing the risk of toxicity. Additionally, its use has declined with the availability of more effective and safer alternatives like inhaled corticosteroids and beta-2 agonists.
## **Correct Answer:** D. adenosine receptors.